YU
IRWD icon

Yale University’s Ironwood Pharmaceuticals IRWD Stock Holding History

Yale University’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,448
Closed -$250K – 8
2015
Q3 		$250K Buy
+7,448
New +$69.5K 0.08% 6

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
Rubric Capital Management (Connecticut) Stamford, Connecticut $6.44M AUM 43.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Yale University's IRWD Position: Q4 2015 in Review

Yale University sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2015, closing a stake of 7,448 shares — an estimated $250K sold.

Yale University first reported a position in IRWD in Q3 2015 and held it in 1 quarter. The position peaked at $250K in Q3 2015. 137 funds tracked by Wall St. Rank hold IRWD as of Q4 2015.

  • Yale University reported no remaining Ironwood Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Yale University sold 7,448 Ironwood Pharmaceuticals shares in Q4 2015, an estimated $250K.
  • Yale University first reported a position in Ironwood Pharmaceuticals in Q3 2015 and held it in 1 quarter.
  • Yale University's Ironwood Pharmaceuticals position peaked at $250K in Q3 2015.
  • 137 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2015.

Based on Yale University's 13F filing for Q4 2015, filed 11 Feb 2016.